We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume | Trades |
---|---|---|---|---|---|---|
LIS | Li S Energy Limited | 0.275 | 0.095 | 52.78% | 10,199,826 | 940 |
AZLO | Arizona Lithium Ltd | 0.003 | 0.001 | 50.00% | 47,000 | 1 |
TKL | Traka Resources Limited | 0.0015 | 0.0005 | 50.00% | 4,846,728 | 3 |
M2ROA | Miramar Resources Limited | 0.003 | 0.001 | 50.00% | 3,984,533 | 4 |
OSLO | OncoSil Medical Ltd | 0.0015 | 0.0005 | 50.00% | 3,150,000 | 4 |
BP8 | BPH Global Ltd | 0.003 | 0.001 | 50.00% | 347,666 | 4 |
MGUO | Magnum Mining and Exploration Ltd | 0.003 | 0.001 | 50.00% | 2,000,000 | 4 |
CXUO | Cauldron Energy Ltd | 0.007 | 0.002 | 40.00% | 368,394 | 4 |
OAU | Ora Gold Limited | 0.011 | 0.003 | 37.50% | 87,303,547 | 220 |
PPK | Ppk Group Limited | 0.64 | 0.17 | 36.17% | 899,463 | 383 |
AZ9O | Asian Battery Metals PLC | 0.04 | 0.01 | 33.33% | 24,501 | 1 |
GlycoMimetics, Inc. (Nasdaq: GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced the Phase 2 analysis of the adaptive Phase 2/3 study of uproleselan being conducted by the National Cancer Institute (NCI) and the Alliance for Clinical Trials in Oncology in adults with newly diagnosed acute myeloid leukemia (AML) who are 60 years or older and fit for intensive chemotherapy. This study did not show a statistically significant improvement in event free survival (EFS) for patients receiving uproleselan in combination with 7+3 chemotherapy versus chemotherapy alone.
GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported its financial results for the third quarter of 2024.
ANDOVER, Mass., Oct. 28, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for the quarter ended September 30, 2024.
Record revenue with Broadband revenue up 92% year over year Video returned to profitability with greater than 10% Adjusted EBITDA margin SAN JOSE, Calif., Oct. 28, 2024 /PRNewswire/ -- Harmonic Inc. (NASDAQ: HLIT) today announced its unaudited results for the third quarter of 2024.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 72,580.01 | 2,658.97 | 3.80% | 1.44T | 7,460,196,855 |
ETH | Ethereum | 2,646.34 | 80.98 | 3.16% | 319.02B | 2,956,760,366 |
USDT | Tether USD | 0.9998 | 0.00047 | 0.05% | 119.63B | 397,854,657 |
BNB | Binance Coin | 609.56 | 9.08 | 1.51% | 96.31B | 197,368,055 |
SOL | Solana | 181.22 | 3.08 | 1.73% | 84.99B | 1,379,640,874 |
USDC | USD Coin | 0.9998 | 0.00 | 0.00% | 35.55B | 1,269,759,676 |
XRP | Ripple | 0.5289 | 0.010 | 1.93% | 29.86B | 191,035,923 |
STETH | stETH | 2,641.33 | 76.74 | 2.99% | 25.98B | 4,797,143 |
DOGE | Dogecoin | 0.17792 | 0.01677 | 10.41% | 26.03B | 1,295,374,477 |
XEC | eCash | 0.000726 | 0.000027 | 3.80% | 14.37B | 101,330,469 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions